Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vikram Babu Kasaragod

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Frontiers in Molecular Neuroscience|August 24, 2019
Structure of Heteropentameric GABA<sub>A</sub> Receptors and Receptor-Anchoring Properties of GephyrinVikram Babu Kasaragod, Hermann Schindelin
Structure (London, England : 1993)|April 27, 2016
Structural Framework for Metal Incorporation during Molybdenum Cofactor BiosynthesisVikram Babu Kasaragod, Hermann Schindelin
ACS Chemical Biology|August 20, 2014
Modulation of gephyrin-glycine receptor affinity by multivalencyHans Michael Maric, Vikram Babu Kasaragod, Hermann Schindelin
Current Opinion in Pharmacology|May 29, 2021
Artemisinins and their impact on inhibitory neurotransmissionAnabel Pacios-Michelena, Vikram Babu Kasaragod, Hermann Schindelin
The European Journal of Neuroscience|August 2, 2019
The P429L loss of function mutation of the human glycine transporter 2 associated with hyperekplexiaAlexandra Kitzenmaier, Natascha Schaefer, Vikram Babu Kasaragod, et al.
Frontiers in Molecular Neuroscience|October 11, 2021
Novel Functional Properties of Missense Mutations in the Glycine Receptor β Subunit in Startle DiseaseInken Piro, Anna-Lena Eckes, Vikram Babu Kasaragod, et al.
Nature Communications|December 23, 2014
Molecular basis of the alternative recruitment of GABA(A) versus glycine receptors through gephyrinHans Michael Maric, Vikram Babu Kasaragod, Torben Johann Hausrat, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 15, 2020
Pyridoxal kinase inhibition by artemisinins down-regulates inhibitory neurotransmissionVikram Babu Kasaragod, Anabel Pacios-Michelena, Natascha Schaefer, et al.
Angewandte Chemie (International Ed. in English)|November 22, 2014
Design and synthesis of high-affinity dimeric inhibitors targeting the interactions between gephyrin and inhibitory neurotransmitter receptorsHans Michael Maric, Vikram Babu Kasaragod, Linda Haugaard-Kedström, et al.
Eneuro|October 30, 2023
Dual Role of Dysfunctional Asc-1 Transporter in Distinct Human Pathologies, Human Startle Disease, and Developmental DelayPaul Drehmann, Sinem Milanos, Natascha Schaefer, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Frontiers in Molecular Neuroscience|August 24, 2019
Structure of Heteropentameric GABA<sub>A</sub> Receptors and Receptor-Anchoring Properties of GephyrinVikram Babu Kasaragod, Hermann Schindelin
Structure (London, England : 1993)|April 27, 2016
Structural Framework for Metal Incorporation during Molybdenum Cofactor BiosynthesisVikram Babu Kasaragod, Hermann Schindelin
ACS Chemical Biology|August 20, 2014
Modulation of gephyrin-glycine receptor affinity by multivalencyHans Michael Maric, Vikram Babu Kasaragod, Hermann Schindelin
Current Opinion in Pharmacology|May 29, 2021
Artemisinins and their impact on inhibitory neurotransmissionAnabel Pacios-Michelena, Vikram Babu Kasaragod, Hermann Schindelin
The European Journal of Neuroscience|August 2, 2019
The P429L loss of function mutation of the human glycine transporter 2 associated with hyperekplexiaAlexandra Kitzenmaier, Natascha Schaefer, Vikram Babu Kasaragod, et al.
Frontiers in Molecular Neuroscience|October 11, 2021
Novel Functional Properties of Missense Mutations in the Glycine Receptor β Subunit in Startle DiseaseInken Piro, Anna-Lena Eckes, Vikram Babu Kasaragod, et al.
Nature Communications|December 23, 2014
Molecular basis of the alternative recruitment of GABA(A) versus glycine receptors through gephyrinHans Michael Maric, Vikram Babu Kasaragod, Torben Johann Hausrat, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 15, 2020
Pyridoxal kinase inhibition by artemisinins down-regulates inhibitory neurotransmissionVikram Babu Kasaragod, Anabel Pacios-Michelena, Natascha Schaefer, et al.
Angewandte Chemie (International Ed. in English)|November 22, 2014
Design and synthesis of high-affinity dimeric inhibitors targeting the interactions between gephyrin and inhibitory neurotransmitter receptorsHans Michael Maric, Vikram Babu Kasaragod, Linda Haugaard-Kedström, et al.
Eneuro|October 30, 2023
Dual Role of Dysfunctional Asc-1 Transporter in Distinct Human Pathologies, Human Startle Disease, and Developmental DelayPaul Drehmann, Sinem Milanos, Natascha Schaefer, et al.
Pageof 2